// App-Quantinova.ai

7 : Concordance of tumor and immune cell staining with Ventana SP142, Ventana SP263, Dako 28-8 and Dako 22C3 PD-L1 tests in NSCLC patient samples.

Researchers

Presenter

  • Marietta Scott

Principal Investigators

  • Marianne J Ratcliffe

  • Alan Sharpe

  • Craig Barker

  • Paul Scorer

  • Marlon Rebelatto

  • Hytham Al-Masri

  • Jill Walker

Medical Centers

  • AstraZeneca, Alderley Park, United Kingdom

  • MedImmune, Gaithersburg, MD

  • Hematogenix, Tinley Park, IL

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Programmed death-ligand 1

Drug/Treatment

  • SP263

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved